The folate puzzle. Part IV: Folate and depression

Drugs of the Future

Volumn 33, Issue 7, 2008, Pages 591-595

  Pauwels, Ernest K J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIDEPRESSANT AGENT; CYANOCOBALAMIN; FLUOXETINE; FOLIC ACID; HOMOCYSTEINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TETRAHYDROBIOPTERIN; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFICACY; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR DEPRESSION; MONOTHERAPY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; REMISSION; REVIEW;

EID: 56749098446     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2008.033.07.1236397     Document Type: Review

References (38)

1. Romans, S.E., Tyas, J., Cohen, M.M., Silverstone, T. Gender differences in the symptoms of major depressive disorder. J Nerv Ment Dis 2007, 195(11): 905-11.
2. Andrews, G., Poulton, R., Skoog, I. Lifetime risk of depression: Restricted to a minority or waiting for most? Br J Psychiatry 2005, 187: 495-6.
3. Sobocki, P., Jönsson, B., Angst, J., Rehnberg, C. Cost of depression in Europe. J Ment Health Policy Econ 2006, 9(2): 87-98.
4. Lorant, V., Croux, C., Weich, S., Deliège, D., Mackenbach, J., Ansseau, M. Depression and socio-economic risk factors: 7-Year longitudinal population study. Br J Psychiatry 2007, 190: 293-8.
5. Targosz, S., Bebbington, P., Lewis, G., Brugha, T., Jenkins, R., Farrell, M., Meltzer, H. Lone mothers, social exclusion and depression. Psychol Med 2003, 33(4): 715-22.
6. Jureidini, J., Tonkin, A. Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 2006, 20(8): 623-32.
7. Geddes, J.R., Furukawa, T.A., Cipriani, A., Barbui, C. Depressive disorder needs an evidence base commensurate with its public health importance. Can J Psychiatry 2007, 52(9): 543-4.
8. Rihmer, Z., Gonda, X. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed? J Affect Disord 2008, Epub ahead of print.
9. Sneed, J.R., Rutherford, B.R., Rindskopf, D., Lane, D.T., Sackeim, H.A., Roose, S.P. Design makes a difference: A meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008, 16(1): 65-73.
10. Folstein, M., Liu, T., Peter, I., Buell, J., Arsenault, L., Scott, T., Qiu, W.W. The homocysteine hypothesis of depression. Am J Psychiatry 2007, 164(6): 861-7.
11. Bottiglieri, T., Laundy, M., Crellin, R., Toone, B.K., Carney, M.W., Reynolds, E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000, 69(2): 228-32.
12. Bjelland, I., Tell, G.S., Vollset, S.E., Refsum, H., Ueland, P.M. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003, 60(6): 618-26.
13. Tolmunen, T., Hintikka, J., Voutilainen, S. et al. Association between depressive symptoms and serum concentrations of homocysteine in men: A population study. Am J Clin Nutr 2004, 80(6): 1574-8.
14. Morris, M.S., Fava, M., Jacques, P.F., Selhub, J., Rosenberg, I.H. Depression and folate status in the US population. Psychother Psychosom 2003, 72(2): 80-7.
15. Tiemeier, H., van Tuijl, H.R., Hofman, A., Meijer, J., Kiliaan, A.J., Breteler, M.M. Vitamin B12, folate, and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002, 159(12): 2099-101.
16. Penninx, B.W., Guralnik, J.M., Ferrucci, L., Fried, L.P., Allen, R.H., Stabler, S.P. Vitamin B(12) deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women's Health and Aging Study. Am J Psychiatry 2000, 157(5): 715-21.
17. Pauwels, E.K.J. The folate puzzle. Part I: The Janus face of folate in cancer medicine. Drugs Fut 2008, 33(4): 247-53.
18. Kaufman, S. Some metabolic relationships between biopterin and folate: Implications for the "methyl trap hypothesis". Neurochem Res 1991, 16(9): 1031-6.
19. Lewis, S.J., Lawlor, D.A., Davey Smith, G., Araya, R., Timpson, N., Day, I.N., Ebrahim, S. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006, 11(4): 352-60.
20. Clarke, R., Armitage, J., Lewington, S., Collins, R., B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of vascular disease: Protocol for a collaborative meta-analysis. Clin Chem Lab Med 2007, 45(12): 1575-81.
21. Narushima, K., Kosier, J.T., Robinson, R.G. A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003, 15(4): 422-30.
22. Robinson, R.G. Poststroke depression: Prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003, 54(3): 376-87.
23. Obeid, R., McCaddon, A., Herrmann, W. The role of hyper-homocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 2007, 45(12): 1590-606.
24. Bottiglieri, T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29(7): 1103-12.
25. Hillemacher, T., Frieling, H., Muschler, M.A., Bleich, S. Homocysteine and epigenetic DNA methylation: A biological model for depression? Am J Psychiatry 2007, 164(10): 1610.
26. Mill, J., Petronis, A. Molecular studies of major depressive disorder: The epigenetic perspective. Mol Psychiatry 2007, 12(9): 799-814.
27. Reynolds, E.H., Preece, J.M., Bailey, J., Coppen, A. Folate deficiency in depressive illness. Br J Psychiatry 1970, 117(538): 287-92.
28. Reynolds, E.H., Carney, M.W., Toone, B.K. Methylation and mood. Lancet 1984, 2(8396): 196-8.
29. Sachdev, P.S., Parslow, R.A., Lux, O. et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med 2005, 35(4): 529-38.
30. Taylor, M.J., Carney, S.M., Goodwin, G.M., Geddes, J.R. Folate for depressive disorders: Systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004, 18(2): 251-6.
31. Gariballa, S., Forster, S. Effects of dietary supplements on depressive symptoms in older patients: A randomised double-blind placebo-controlled trial. Clin Nutr 2007, 26(5): 545-51.
32. Coppen, A., Bailey, J. Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. J Affect Disord 2000, 60(2): 121-30.
33. Abou-Saleh, M.T., Coppen, A. Folic acid and the treatment of depression. J Psychosom Res 2006, 61(3): 285-7.
34. Kim, Y.I. Folic acid fortification and supplementation - Good for some but not so good for others. Nutr Rev 2007, 65(11): 504-11.
35. Gilbody, S., Lightfoot, T., Sheldon, T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 2007, 61(7): 631-7.
36. Roberts, S.H., Bedson, E., Hughes, D. et al. Folate augmentation of treatment - evaluation for depression (FolATED): Protocol of a randomised controlled trial. BMC Psychiatry 2007, 7: 65.
37. Warden, D., Rush, AJ., Trivedi, M.H., Fava, M., Wisniewski, S.R. The STARD Project results: A comprehensive review of findings. Curr Psychiatry Rep 2007, 9(6): 449-59.
38. Fava, M. Augmenting antidepressants with folate: A clinical perspective. J Clin Psychiatry 2007, 68(Suppl. 10): 4-7.